📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis (2023)

First Author: Jindani A

Attributed to: Epidemiological and statistical research on health problems of low and middle-income countries: MRC Tropical Epidemiology Group (TEG) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/evidoa2300054

PubMed Identifier: 38320155

Publication URI: http://europepmc.org/abstract/MED/38320155

Type: Journal Article/Review

Parent Publication: NEJM Evidence

Issue: 9

ISSN: 2766-5526